Price T Rowe Associates Inc Revolution Medicines, Inc. Transaction History

Price T Rowe Associates Inc

$883 Billion
Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 4,701,962 shares of RVMD stock, worth $166 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,701,962

Previous 5,599,642 16.03%

Holding current value

$166 Million

Previous $198 Million 12.64%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$31.13 - $41.98 $27.9 Million - $37.7 Million	-897,680 Reduced 16.03%	4,701,962 $173 Million
Q1 2025 May 14, 2025	SELL	$35.36 - $44.42 $9.42 Million - $11.8 Million	-266,320 Reduced 4.54%	5,599,642 $198 Million
Q4 2024 Feb 14, 2025	BUY	$42.97 - $60.6 $23.7 Million - $33.5 Million	552,657 Added 10.4%	5,865,962 $257 Million
Q3 2024 Nov 14, 2024	BUY	$36.92 - $47.94 $3.57 Million - $4.63 Million	96,646 Added 1.85%	5,313,305 $241 Million
Q2 2024 Aug 14, 2024	BUY	$30.14 - $40.68 $12.1 Million - $16.4 Million	402,349 Added 8.36%	5,216,659 $202 Million
Q1 2024 May 15, 2024	BUY	$26.56 - $33.55 $4.73 Million - $5.97 Million	177,957 Added 3.84%	4,814,310 $155 Million
Q4 2023 Feb 14, 2024	SELL	$18.35 - $34.12 $8.41 Million - $15.6 Million	-458,353 Reduced 9.0%	4,636,353 $133 Million
Q3 2023 Nov 14, 2023	BUY	$25.17 - $35.05 $1.91 Million - $2.66 Million	75,941 Added 1.51%	5,094,706 $141 Million
Q2 2023 Aug 14, 2023	SELL	$20.28 - $27.0 $332,875 - $443,178	-16,414 Reduced 0.33%	5,018,765 $134 Million
Q1 2023 May 15, 2023	BUY	$20.76 - $30.09 $28.1 Million - $40.8 Million	1,355,137 Added 36.82%	5,035,179 $109 Million
Q4 2022 Feb 14, 2023	BUY	$17.68 - $25.53 $484,679 - $699,879	27,414 Added 0.75%	3,680,042 $87.7 Million
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $24.7 Million - $36.8 Million	1,414,774 Added 63.22%	3,652,628 $72 Million
Q2 2022 Aug 15, 2022	SELL	$14.54 - $27.17 $900,927 - $1.68 Million	-61,962 Reduced 2.69%	2,237,854 $43.6 Million
Q1 2022 May 16, 2022	BUY	$17.31 - $26.4 $21.5 Million - $32.8 Million	1,244,045 Added 117.83%	2,299,816 $58.7 Million
Q4 2021 Feb 14, 2022	BUY	$24.35 - $33.7 $874,773 - $1.21 Million	35,925 Added 3.52%	1,055,771 $26.6 Million
Q3 2021 Nov 15, 2021	BUY	$23.95 - $33.41 $24 Million - $33.5 Million	1,001,922 Added 5589.83%	1,019,846 $28.1 Million
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $59,421 - $97,204	2,049 Added 12.91%	17,924 $569,000
Q1 2021 May 17, 2021	SELL	$37.21 - $54.43 $2.86 Million - $4.19 Million	-76,945 Reduced 82.9%	15,875 $728,000
Q4 2020 Feb 16, 2021	BUY	$30.19 - $45.49 $2.8 Million - $4.22 Million	92,820 New	92,820 $3.68 Million

Others Institutions Holding RVMD

# of Institutions

330

Shares Held

195M

Call Options Held

890K

Put Options Held

717K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.09B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Revolution Medicines, Inc. Transaction History